Overview

FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Find a genetic signature of de novo resistance to letrozole in adjuvant breast cancer;
Phase:
Phase 2
Details
Lead Sponsor:
Jules Bordet Institute
Collaborators:
Feculdade de Medicina da Universidade de Sao Paulo - Brasil
Hospital de Clinicas de Porto Alegre
Hospital do Cancer, Sao Paulo
Treatments:
Letrozole